UCB PHARMA S.A.

BRUSSELS, BE

1. 20090239263 Expression Control Using Antibody Expression Optimisation Sequences 09-24-2009
2. 20090149437 THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS 06-11-2009
3. 20090117126 Neutralising Antibody Molecules Having Specificity for Human IL-17 05-07-2009
4. 20090075398 Method for Obtaining Antibodies - method of obtaining at least one recombinant antibody with improved affinity for a selected antigen from a family of 03-19-2009
5. 20080306246 Process for Attaching Effector Molecules to Proteins 12-11-2008
6. 20080306060 Fused Thiazole Derivatives as Kinase Inhibitors 12-11-2008
7. 20080269466 Modified Antibody Fragments - new class of modified antibody fragments 10-30-2008
8. 20080269465 BIOLOGICAL PRODUCTS - There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for 10-30-2008
9. 20080220005 Comb Polymers - process for producing a comb polymer comprising the steps of 09-11-2008